Austin Health

Title
Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database.
Publication Date
2023-01
Author(s)
Margalit, Ofer
Harmsen, William S
Shacham-Shmueli, Einat
Voss, Molly M
Boursi, Ben
Wagner, Anna D
Cohen, Romain
Olswold, Curtis L
Saltz, Leonard B
Goldstein, Daniel A
Hurwitz, Herbert
Tebbutt, Niall C
Kabbinavar, Fairooz F
Adams, Richard A
Chibaudel, Benoist
Grothey, Axel
Yoshino, Takayuki
Zalcberg, John
de Gramont, Aimery
Shi, Qian
Lenz, Heinz-Josef
Subject
ARCAD
Age
Bevacizumab
Colorectal carcinoma
Metastatic
Sex
Type of document
Journal Article
OrcId
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
DOI
10.1016/j.ejca.2022.10.022
Abstract
Previous studies suggest a possible sex-specific response to bevacizumab in metastatic colorectal carcinoma (mCRC), showing a benefit in males, while the effect in females is less significant.
Link
link
Citation
European Journal of Cancer 2023; 178
Jornal Title
European Journal of Cancer (Oxford, England : 1990)
ISSN
1879-0852

Files:

NameSizeformatDescriptionLink